ROMARK ANNOUNCES FDA APPROVAL OF NEW MANUFACTURING FACILITY IN MANATI, PUERTO RICO
TAMPA, Fla. - August 20, 2020 – Romark, a research-based pharmaceutical company focused on the discovery, development and delivery of innovative new medicines, primarily in the field of infectious diseases, announced today that the U.S. Food and Drug Administration (FDA) has approved the company's manufacturing facility in Manati, Puerto Rico for the production of ALINIA® (nitazoxanide)